247 related articles for article (PubMed ID: 10753532)
1. Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity.
Eroglu A; Kocaoglu H; Demirci S; Akgül H
Eur J Surg Oncol; 2000 Apr; 26(3):213-21. PubMed ID: 10753532
[TBL] [Abstract][Full Text] [Related]
2. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
[TBL] [Abstract][Full Text] [Related]
3. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.
Deroose JP; Eggermont AM; van Geel AN; Burger JW; den Bakker MA; de Wilt JH; Verhoef C
J Clin Oncol; 2011 Oct; 29(30):4036-44. PubMed ID: 21931039
[TBL] [Abstract][Full Text] [Related]
6. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.
Grunhagen DJ; de Wilt JH; Graveland WJ; Verhoef C; van Geel AN; Eggermont AM
Cancer; 2006 Apr; 106(8):1776-84. PubMed ID: 16541435
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
[TBL] [Abstract][Full Text] [Related]
8. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
9. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.
Thijssens KM; van Ginkel RJ; Pras E; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2006 Apr; 13(4):518-24. PubMed ID: 16485147
[TBL] [Abstract][Full Text] [Related]
10. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
[TBL] [Abstract][Full Text] [Related]
11. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
12. Isolated limb infusion for advanced soft tissue sarcoma of the extremity.
Moncrieff MD; Kroon HM; Kam PC; Stalley PD; Scolyer RA; Thompson JF
Ann Surg Oncol; 2008 Oct; 15(10):2749-56. PubMed ID: 18648882
[TBL] [Abstract][Full Text] [Related]
13. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
[TBL] [Abstract][Full Text] [Related]
14. Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas.
Deroose JP; Grünhagen DJ; de Wilt JH; Eggermont AM; Verhoef C
Eur J Cancer; 2015 Feb; 51(3):367-73. PubMed ID: 25529370
[TBL] [Abstract][Full Text] [Related]
15. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
[TBL] [Abstract][Full Text] [Related]
17. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes.
Cormier JN; Huang X; Xing Y; Thall PF; Wang X; Benjamin RS; Pollock RE; Antonescu CR; Maki RG; Brennan MF; Pisters PW
J Clin Oncol; 2004 Nov; 22(22):4567-74. PubMed ID: 15542808
[TBL] [Abstract][Full Text] [Related]
18. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
19. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
20. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
Cherix S; Speiser M; Matter M; Raffoul W; Liénard D; Theumann N; Mouhsine E; Mirimanoff RO; Leyvraz S; Lejeune FJ; Leyvraz PF
J Surg Oncol; 2008 Sep; 98(3):148-55. PubMed ID: 18668638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
